Clinical Trial Update: Body Surface Gastric Mapping in Patients on Semaglutide

View source ↗

Summary

A clinical trial is evaluating body surface gastric mapping in patients taking semaglutide to study gastric motility, with recruitment ongoing.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastroparesis

Drugs mentioned

• OZEMPIC (semaglutide)

Snippet

Sponsor: University of Western Sydney | Conditions: Semaglutide-Induced Gastric Motility, Gastroparesis | Status: RECRUITING